-

Ambac Reports First Quarter 2025 Results

  • Total revenue from continuing P&C operations increased 27% for the quarter to $63 million
  • Total P&C premium production increased 70% for the quarter to $318 million

NEW YORK--(BUSINESS WIRE)--Ambac Financial Group, Inc. (NYSE: AMBC) ("Ambac" or "AFG"), an insurance holding company, today reported its results for the First Quarter 2025.

First Quarter 2025 vs. First Quarter 2024 Segment Highlights

  • Insurance Distribution ("Cirrata")
    • Total revenue grew to $41 million for the quarter, an increase of 129%
    • Net loss to Shareholders of $(2) million for the quarter, down 145%, with a (4.3)% margin vs. 21.2%
    • Adjusted EBITDA of $12 million for the quarter, up 136%, with a 29.5% margin vs. 28.7%
    • Adjusted EBITDA to Shareholders of $7 million for the quarter, up 69%, with a 17.3% margin vs. 23.5%
  • Specialty P&C Insurance ("Everspan")
    • Loss ratio of 66.9% improved by -880 bps and Combined ratio of 102.1% up 370 bps
    • Net income to Shareholders of over $1 million for the quarter, down slightly
    • Adjusted EBITDA to Shareholders of under $2 million for the quarter, down slightly

Claude LeBlanc, President and Chief Executive Officer, stated, "Our P&C business had a strong start to the year, with premium production up 70% to $318 million and revenue up 27% to $63 million, both compared to the first quarter of 2024, bolstered by our acquisition of Beat. Our increasingly diversified portfolio is being built for long-term growth and to withstand market cyclicality, such as the headwinds experienced in property and ESL this quarter. We are positioned to continue growing our business by focusing on specialty niches, and I am encouraged by the early indications from the MGAs we launched last year, a few of which are already profitable and all of which are trending towards consistent profitability."

LeBlanc continued, “In addition, as previously announced, we have completed all of our pre-closing conditions related to the sale of our Legacy business, which remains subject only to Wisconsin regulatory approval. We eagerly await the close of this transaction as we look ahead to our future as a leading specialty P&C franchise."

Ambac's First Quarter 2025 Summary Results

 

 

Three months ended March 31,

 

($ in thousands, except per share data)1

 

 

2025

 

 

 

2024

 

% Change

Total revenues from continuing operations

 

 

62,756

 

 

 

49,551

 

27%

Total expenses from continuing operations

 

 

77,863

 

 

 

52,790

 

47%

Pretax income (loss) from continuing operations

 

 

(15,107

)

 

 

(3,239

)

366%

Provision (benefit) for income taxes from continuing operations

 

 

(617

)

 

 

130

 

(575)%

Net income (loss) from continuing operations

 

 

(14,490

)

 

 

(3,369

)

330%

Net income (loss) from continuing operations attributable to Ambac shareholders

 

 

(16,144

)

 

 

(4,070

)

297%

Net income (loss) from discontinued operations

 

 

(30,247

)

 

 

24,140

 

(225)%

Net income (loss) attributable to Ambac shareholders

 

 

(46,391

)

 

 

20,070

 

(331)%

Net income (loss) attributable to common stockholders per diluted share 3

 

$

(1.22

)

 

$

0.44

 

(377)%

Non-GAAP

 

 

 

 

 

EBITDA to shareholders 2

 

 

(5,477

)

 

 

(1,627

)

237%

Adjusted EBITDA to shareholders2

 

 

(1,287

)

 

 

384

 

(435)%

Adjusted net income (loss) attributable to shareholders

 

 

(6,037

)

 

 

(329

)

1735%

Per Share

 

 

 

 

 

Adjusted net income (loss) to shareholders per diluted share 2

 

$

(0.13

)

 

$

(0.01

)

NM

Adjusted EBITDA to shareholders per diluted share2

 

$

(0.03

)

 

$

0.01

 

(400)%

 

 

 

 

 

 

Weighted-average diluted shares outstanding (in millions)

 

 

47,313

 

 

 

45,827

 

 

(1)

Some financial data in this press release may not add up due to rounding

(2)

See Non-GAAP Financial Data section of this press release for further information

(3)

Per diluted share includes the impact of adjusting redeemable noncontrolling interests to current redemption value

 

First Quarter 2025 Summary*

Total revenue from continuing operations for the first quarter of 2025 was $63 million, an increase of 27% compared to the $50 million in the same prior-year period. This increase was primarily due to the inclusion of Beat Capital, which more than offset a managed reduction to earned premium at Everspan following last year's decision to exit several programs. Organic growth at Cirrata met headwinds in certain A&H lines, which more than offset organic expansion across other programs.

Total expenses from continuing operations for the first quarter of 2025 were $78 million, an increase of 48% compared to the $53 million in the same prior-year period. The increase was primarily due to an increase in G&A expenses from the inclusion of Beat, professional and advisor fees related to transactions, and intangible amortization and interest expense, both of which relate to the Beat acquisition. These increases more than offset the lower losses and loss adjustment expenses at Everspan from the exit of several retained programs.

Net loss from continuing operations to Ambac shareholders for the first quarter of 2025 increased by $12 million to $(16) million compared to the $(4) million in the same prior-year period. The increase was driven by increased intangible amortization and interest expense related to the acquisition of Beat.

Adjusted EBITDA from continuing operations to Ambac shareholders for the first quarter of 2025 was $(1) million compared to $0 million in the same prior-year period. For the quarter, Cirrata's $3 million increase in Adjusted EBITDA over the same prior-year period was more than offset by elevated holding company expenses, which included an allocation adjustment related to discontinued operations, a portion of which will unwind in connection with the closing of the sale of the Legacy business, and a slight contraction at Everspan. For the quarter, the consolidated Adjusted EBITDA margin, prior to any reduction for non-controlling interests, was 5.9% compared to 2.6% in the same prior-year period.

* For definition of each non-GAAP measures referred to above, as well as reconciliation of such non-GAAP measures to their most directly comparable GAAP measures, see "Non-GAAP Financial Measures" below.

Earnings Call and Webcast

On May 13, 2025, at 8:30am ET, Claude LeBlanc, President and Chief Executive Officer, and David Trick, Executive Vice President and Chief Financial Officer, will discuss Ambac's first quarter 2025 results during a conference call. A live audio webcast of the call will be available through the Investor Relations section of Ambac’s website, https://ambac.com/investor-relations/events-and-presentations/. Participants may also listen via telephone by dialing (877) 407-9716 (Domestic) or (201) 493-6779 (International).

The webcast will be archived on Ambac's website. A replay of the call will be available through May 27, 2025, and can be accessed by dialing (Domestic) (844) 512-2921 or (International) (412) 317-6671; and using ID#13753308

Additional information is included in an operating supplement and presentations at Ambac's website at www.ambac.com.

Results of Operations by Segment

Insurance Distribution Segment

 

 

 

Three Months Ended March 31,

($ in thousands)

 

 

 

2025

 

 

 

2024

 

 

% Change

Total revenues

 

 

$

40,998

 

 

$

17,865

 

 

129%

Pretax income (loss)

 

 

$

(2,243

)

 

$

3,973

 

 

(156)%

Pretax income (loss) to shareholders

 

 

$

(3,897

)

 

$

3,270

 

 

(219)%

EBITDA to shareholders

 

 

$

7,083

 

 

$

4,202

 

 

69%

Adjusted EBITDA

 

 

$

12,112

 

 

$

5,122

 

 

136%

Adjusted EBITDA to shareholders

 

 

$

7,112

 

 

$

4,202

 

 

69%

Pretax income margin to shareholders1

 

 

 

(5.5

)%

 

 

22.2

%

 

(1248) bps

Adjusted EBITDA margin to shareholders2

 

 

 

17.3

%

 

 

23.5

%

 

(264) bps

Organic Growth

 

 

 

(2.1

)%

 

 

7.7

%

 

 

(1)

Represents Pretax income divided by total revenues

(2)

See Non-GAAP Financial Data section of this press release for further information

 

Specialty Property & Casualty Insurance Segment

 

 

 

Three Months Ended March 31,

($ in thousands)

 

 

 

2025

 

 

 

2024

 

 

% Change

Gross premium written

 

 

$

86,915

 

 

$

96,422

 

 

(10)%

Net premiums written

 

 

$

18,005

 

 

$

26,247

 

 

(31)%

Net premiums earned

 

 

$

15,678

 

 

$

25,579

 

 

(39)%

Total revenue

 

 

$

21,171

 

 

$

29,542

 

 

(28)%

Net income (loss) from continuing operations

 

 

$

1,425

 

 

$

1,715

 

 

(17)%

Adjusted EBITDA to shareholders

 

 

$

1,589

 

 

$

1,872

 

 

(15)%

Loss Ratio

 

 

 

66.9

%

 

 

75.7

%

 

-880 bps

Expense Ratio

 

 

 

35.2

%

 

 

22.7

%

 

1250 bps

Combined Ratio

 

 

 

102.1

%

 

 

98.4

%

 

370 bps

(1)

See Non-GAAP Financial Data section of this press release for further information

 

AFG Corporate (holding company only)

AFG on a standalone basis, excluding its ownership interests in its Specialty P&C Insurance, Insurance Distribution, and Legacy Financial Guarantee subsidiaries, had net assets of $104 million as of March 31, 2025. Assets included cash and liquid securities of $54 million and other investments of $29 million.

Capital Activity

During the first quarter of 2025 we repurchased 264,791 shares at an average price of $11.79 per share. There is approximately $35.2 million remaining on the current repurchase authorization.

Consolidated Ambac Financial Group, Inc. Stockholders' Equity and NCI Impact to EPS

Stockholders’ equity at March 31, 2025, was $852 million, or $18.36 per share compared to $857 million or $18.43 per share as of December 31, 2024. The net loss attributable to common shareholders of $(46) million was offset by net unrealized investment gains of $19 million and foreign exchange translation gains of $36 million.

Calculation of Earnings Per Share

Diluted net income per share is computed by dividing net income attributable to shareholders, including adjustments to the redemption value of redeemable noncontrolling interests, by the basic weighted-average shares outstanding plus all potentially dilutive common shares outstanding during the period. The following table provides a reconciliation of net income attributable to shareholders to the numerator in the diluted earnings per share calculation, together with the resulting earnings per share amounts:

($ in thousands, except share data)

 

Three Months Ended
March 31,

 

 

 

2025

 

 

 

2024

 

Net income (loss) from continuing operations attributable to shareholders

 

$

(16,144

)

 

$

(4,070

)

Adjustment for Redeemable NCI

 

$

(11,183

)

 

$

53

 

Numerator of diluted EPS

 

$

(27,327

)

 

$

(4,017

)

Per Share — Diluted

 

$

(0.58

)

 

$

(0.09

)

 

 

 

 

 

Net income (loss) attributable to Ambac shareholders

 

$

(46,391

)

 

$

20,070

 

Adjustment for Redeemable NCI

 

 

(11,183

)

 

 

53

 

Numerator of diluted EPS

 

$

(57,574

)

 

$

20,123

 

Per Share — Diluted

 

$

(1.22

)

 

$

0.44

 

 

 

 

 

 

WASO-Diluted

 

 

47,313

 

 

 

45,827

 

 

AMBAC FINANCIAL GROUP, INC. AND SUBSIDIARIES
Consolidated Statements of Income (Loss) (Unaudited)

 

 

 

Three Months Ended

March 31,

($ in thousands, except share data)

 

 

2025

 

 

 

2024

 

Revenues:

 

 

 

 

Net premiums earned

 

$

15,678

 

 

$

25,579

 

Commission income

 

 

36,771

 

 

 

17,729

 

Servicing and other fees

 

 

4,964

 

 

 

 

Program fees

 

 

3,652

 

 

 

2,567

 

Net investment income

 

 

2,815

 

 

 

3,640

 

Other revenue

 

 

(1,124

)

 

 

36

 

Total revenues and other income

 

 

62,756

 

 

 

49,551

 

Expenses:

 

 

 

 

Losses and loss adjustment expenses

 

 

10,496

 

 

 

19,355

 

Policy acquisition costs

 

 

3,841

 

 

 

4,424

 

Commission expense

 

 

10,365

 

 

 

9,822

 

General and administrative expenses

 

 

38,531

 

 

 

17,575

 

Intangible amortization and depreciation

 

 

9,176

 

 

 

1,614

 

Interest expense

 

 

5,454

 

 

 

 

Total expenses

 

 

77,863

 

 

 

52,790

 

Pretax income (loss) from continuing operations

 

 

(15,107

)

 

 

(3,239

)

Provision (benefit) for income taxes from continuing operations

 

 

(617

)

 

 

130

 

Net income (loss) from continuing operations

 

$

(14,490

)

 

$

(3,369

)

Net income (loss) from discontinued operations

 

 

(30,247

)

 

 

24,140

 

Net income (loss)

 

 

(44,737

)

 

 

20,771

 

Less: net (gain) loss attributable to noncontrolling interest

 

 

(1,654

)

 

 

(701

)

Net income (loss) attributable to Ambac shareholders

 

$

(46,391

)

 

$

20,070

 

 

 

 

 

 

Net income (loss) from continuing operations per share attributable to Ambac shareholders

 

 

 

 

Basic

 

$

(0.58

)

 

$

(0.09

)

Diluted

 

$

(0.58

)

 

$

(0.09

)

Net income (loss) from discontinued operations per share attributable to Ambac shareholders

 

 

 

 

Basic

 

$

(0.64

)

 

$

0.53

 

Diluted

 

$

(0.64

)

 

$

0.53

 

Net income (loss) per share attributable to Ambac shareholders

 

 

 

 

Basic

 

$

(1.22

)

 

$

0.44

 

Diluted

 

$

(1.22

)

 

$

0.44

 

 

 

 

 

 

Weighted-average number of common shares outstanding:

 

 

 

 

Basic

 

 

47,313,012

 

 

 

45,827,076

 

Diluted

 

 

47,313,012

 

 

 

45,827,076

 

 

AMBAC FINANCIAL GROUP, INC. AND SUBSIDIARIES
Consolidated Balance Sheets (Unaudited)

 
 

($ in thousands, except share data)

 

March 31,
2025

 

December 31,
2024

Assets:

 

 

 

 

Investments:

 

 

 

 

Fixed maturity securities, at fair value (amortized cost: $164,688 and $162,124)

 

$

161,569

 

 

$

157,020

 

Short-term investments, at fair value (amortized cost: $101,604 and $127,588)

 

 

101,610

 

 

 

127,601

 

Other investments (includes $7,420 and $7,499 at fair value)

 

 

28,214

 

 

 

28,294

 

Total investments (net of allowance for credit losses of $0 and $0)

 

 

291,393

 

 

 

312,915

 

Cash and cash equivalents

 

 

34,064

 

 

 

29,606

 

Restricted cash

 

 

17,596

 

 

 

17,669

 

Cash and cash equivalents (including $17,596 and $17,669 of restricted cash)

 

 

51,660

 

 

 

47,275

 

Premium receivables (net of allowance for credit losses of $142 and $142)

 

 

64,563

 

 

 

57,222

 

Commission and fees receivable

 

 

55,377

 

 

 

55,377

 

Deferred acquisition costs

 

 

9,615

 

 

 

8,572

 

Reinsurance recoverable on paid and unpaid losses (net of allowance for credit losses of $100 and $100)

 

 

351,110

 

 

 

306,191

 

Deferred ceded premium

 

 

144,914

 

 

 

148,300

 

Intangible assets, less accumulated amortization

 

 

345,061

 

 

 

344,775

 

Goodwill

 

 

429,314

 

 

 

418,234

 

Other assets

 

 

107,829

 

 

 

92,317

 

Assets held-for-sale

 

 

6,392,004

 

 

 

6,267,200

 

Total assets

 

$

8,253,282

 

 

$

8,058,378

 

Liabilities and Stockholders’ Equity:

 

 

 

 

Liabilities:

 

 

 

 

Unearned premiums

 

$

181,387

 

 

$

182,446

 

Loss and loss adjustment expense reserves

 

 

373,105

 

 

 

349,062

 

Ceded premiums payable

 

 

81,358

 

 

 

53,002

 

Deferred program fees and reinsurance commissions

 

 

7,176

 

 

 

7,500

 

Deferred taxes

 

 

69,742

 

 

 

70,135

 

Short-term debt

 

 

150,000

 

 

 

150,000

 

Accrued interest payable

 

 

2,695

 

 

 

2,560

 

Other liabilities

 

 

91,429

 

 

 

89,036

 

Liabilities held-for-sale

 

 

5,887,685

 

 

 

5,887,685

 

Total liabilities

 

 

7,041,817

 

 

 

6,862,857

 

 

 

 

 

 

Redeemable noncontrolling interest

 

 

185,417

 

 

 

140,860

 

Stockholders’ equity:

 

 

 

 

Preferred stock, par value $0.01 per share; 20,000,000 shares authorized shares; issued and outstanding shares—none

 

 

 

 

 

 

Common stock, par value $0.01 per share; 130,000,000 shares authorized; issued shares: 48,875,167 and 48,875,167

 

 

489

 

 

 

489

 

Additional paid-in capital

 

 

333,356

 

 

 

331,007

 

Accumulated other comprehensive income (loss)

 

 

(133,168

)

 

 

(188,436

)

Retained earnings

 

 

681,489

 

 

 

742,185

 

Treasury stock, shares at cost: 2,447,746 and 2,368,194

 

 

(29,945

)

 

 

(28,339

)

Total Ambac Financial Group, Inc. stockholders’ equity

 

 

852,221

 

 

 

856,906

 

Nonredeemable noncontrolling interest

 

 

173,827

 

 

 

197,755

 

Total stockholders’ equity

 

 

1,026,048

 

 

 

1,054,661

 

Total liabilities, redeemable noncontrolling interest and stockholders’ equity

 

$

8,253,282

 

 

$

8,058,378

 

 

Non-GAAP Financial Data

In addition to reporting the Company’s quarterly financial results in accordance with GAAP, the Company is reporting non-GAAP financial measures: EBITDA, Adjusted EBITDA and Adjusted EBITDA Margin, Organic Revenue Growth Rate (Insurance Distribution segment only), Adjusted Net Income and Adjusted Net Income Margin. These amounts are derived from our consolidated financial information, but are not presented in our consolidated financial results.

We present non-GAAP supplemental financial information because we believe such information is of interest to the investment community, and that it provides greater transparency and enhanced visibility into the underlying drivers and performance of our businesses on a basis that may not be otherwise apparent on a GAAP basis. We view these non-GAAP financial measures as important indicators when assessing and evaluating our performance on a segmented and consolidated basis and they are presented to improve the comparability of our results between periods by eliminating the impact of the items that may not be representative of our core operating performance. These non-GAAP financial measures are not substitutes for the Company’s GAAP reporting, should not be viewed in isolation and may differ from similar reporting provided by other companies, which may define non-GAAP measures differently.

The following paragraphs define each non-GAAP financial measure. A tabular reconciliation of the non-GAAP financial measure and the most comparable GAAP financial measure is also presented below.

Non-GAAP Financial Measures

Organic Revenue Growth & Rate (Insurance Distribution Only.) — Organic revenue is based on commissions and fees for the relevant period by excluding (i) the first twelve months of commissions and fees generated from acquisitions and (ii) commissions and fees from divestitures (iii) and other items such as contingent commissions and the impact of changes in foreign exchange rates.

Organic revenue growth is the change in organic revenue period-to-period, with prior period results adjusted to (i) include commissions and fees that were excluded from organic revenue in the prior period and reached the twelve-month owned mark in the current period, and (ii) exclude commissions and fees related to divestitures from organic revenue.

Total Specialty P&C Insurance Production Specialty P&C Insurance production, which includes gross premiums written by Ambac's Specialty P&C Insurance segment and premiums placed by the Insurance Distribution segment. Specialty P&C Insurance revenues are dependent on gross premiums written, as specialty program insurance companies earn premiums based on the portion of gross premiums written retained (i.e. net premiums written) and fees on gross premiums written that are ceded to reinsurers. Insurance Distribution revenues are dependent on premium volume, as Managing General Agents/Underwriters and brokers receive commissions based on the amount of premiums placed (i.e. gross premiums written on behalf of insurance carriers) with insurance carriers.

EBITDA — EBITDA is net income (loss) before interest expense, income taxes, depreciation and amortization of intangible assets.

Adjusted EBITDA and Adjusted EBITDA Margin — We define Adjusted EBITDA as net income (loss) from continuing operations before interest expense, income taxes, depreciation, amortization of intangible assets, change in fair value of contingent consideration and certain items of income and expense, including share-based compensation expense, acquisition and integration related expenses, severance, and other exceptional or non-recurring items, including those related to raising capital. We believe that adjusted EBITDA is an appropriate measure of operating performance because it eliminates the impact of income and expenses that may obfuscate business performance, and that the presentation of this measure enhances an investor's understanding of our financial performance.

Adjusted Net Income and Adjusted Net Income Margin — We define Adjusted net income as net income (loss) from continuing operations attributable to Ambac adjusted for amortization of intangible assets, change in fair value of contingent consideration and certain items of income and expense, including share-based compensation expense, acquisition and integration related expenses, severance and non-recurring income and loss items that, in the opinion of management, significantly affect the period-over-period assessment of operating results, and the related tax effect of those adjustments. Per share amounts exclude any impact of revaluing non-controlling interests as otherwise reported under GAAP earnings per share. We believe that adjusted net income is an appropriate measure of operating performance because it eliminates the impact of income and expenses that may obfuscate business performance.

Results of Operations by Segment (Continued)

Three Months Ended March 31, 2025

 

Specialty
Property &
Casualty
Insurance

 

Insurance
Distribution

 

Corporate &
Other

 

Consolidated

($ in thousands)

 

 

 

 

 

 

 

 

Gross premiums written

 

$

86,915

 

 

 

 

 

 

$

86,915

 

Net premiums written

 

 

18,005

 

 

 

 

 

 

 

18,005

 

Total revenues from Continuing Operations

 

 

21,171

 

 

 

40,998

 

 

 

587

 

 

 

62,756

 

Total expenses from Continuing Operations

 

 

19,668

 

 

 

43,241

 

 

 

14,954

 

 

 

77,863

 

Pretax income (loss)

 

 

1,503

 

 

 

(2,243

)

 

 

(14,367

)

 

 

(15,107

)

Provision (benefit) for income taxes

 

 

78

 

 

 

(500

)

 

 

(195

)

 

 

(617

)

Net income (loss) from Continuing Operations

 

$

1,425

 

 

$

(1,743

)

 

$

(14,172

)

 

$

(14,490

)

 

 

 

 

 

 

 

 

 

Adjustments to EBITDA

 

 

 

 

 

 

 

 

Add: Interest expense

 

 

 

$

5,454

 

 

 

 

$

5,454

 

Add: Income tax expense

 

 

78

 

 

 

(500

)

 

 

(195

)

 

 

(617

)

Add: Depreciation

 

 

 

 

 

109

 

 

 

305

 

 

 

414

 

Add: Intangible amortization

 

 

 

 

8,763

 

 

 

 

 

8,763

 

EBITDA from Continuing Operations

 

$

1,503

 

 

$

12,083

 

 

$

(14,063

)

 

$

(477

)

EBITDA from Continuing Operations attributable to

Ambac shareholders

 

$

1,503

 

 

$

7,083

 

 

$

(14,063

)

 

$

(5,477

)

 

 

 

 

 

 

 

 

 

Adjustments to Adjusted EBITDA

 

 

 

 

 

 

 

 

Add: Acquisition and integration related expenses

 

$

 

 

$

 

 

$

682

 

 

$

682

 

Add: Equity-based compensation expense

 

 

86

 

 

 

 

 

 

1,574

 

 

 

1,660

 

Add: Severance and restructuring expense

 

 

 

 

 

29

 

 

 

1,819

 

 

 

1,848

 

Adjusted EBITDA from Continuing Operations

 

 

1,589

 

 

 

12,112

 

 

 

(9,988

)

 

 

3,713

 

Adjusted EBITDA from Continuing Operations attributable to

Ambac shareholders

 

$

1,589

 

 

$

7,112

 

 

$

(9,988

)

 

$

(1,287

)

 

 

 

 

 

 

 

 

 

Net income (loss) (Continuing Operations)

 

$

1,425

 

 

$

(1,743

)

 

$

(14,172

)

 

$

(14,490

)

Adjustments:

 

 

 

 

 

 

 

 

Add: Acquisition and integration related expenses

 

 

 

 

 

 

 

 

682

 

 

 

682

 

Add: Intangible amortization

 

 

 

 

 

8,763

 

 

 

 

 

 

8,763

 

Add: Equity-based compensation expense

 

 

86

 

 

 

 

 

 

1,574

 

 

 

1,660

 

Add: Severance and restructuring expense

 

 

 

 

 

29

 

 

 

1,819

 

 

 

1,848

 

Add: Other non-operating (income) losses

 

 

 

 

 

 

 

 

 

 

 

 

Adjusted net income (loss) before tax and NCI

 

 

1,511

 

 

 

7,049

 

 

 

(10,097

)

 

 

(1,537

)

Income tax effects

 

 

 

 

 

 

 

 

 

 

 

 

Adjusted net income (loss) before NCI

 

 

1,511

 

 

 

7,049

 

 

 

(10,097

)

 

 

(1,537

)

Net (income) loss attributable to noncontrolling interest

 

 

 

 

 

(4,500

)

 

 

 

 

 

(4,500

)

Adjusted net income (loss) attributable to common shareholders

 

$

1,511

 

 

$

2,549

 

 

$

(10,097

)

 

$

(6,037

)

 

 

 

 

 

 

 

 

 

Net income (loss) margin

 

 

6.7

%

 

 

(4.3

)%

 

 

NM

 

 

 

(23.1

)%

Adjusted EBITDA Margin

 

 

7.5

%

 

 

29.5

%

 

 

NM

 

 

 

5.9

%

Adjusted EBITDA Margin to Ambac shareholders

 

 

7.5

%

 

 

17.3

%

 

 

NM

 

 

 

(2.1

)%

Adjusted Net income (loss) after NCI margin

 

 

7.1

%

 

 

23.0

%

 

 

NM

 

 

 

(2.9

)%

 
 

Three Months Ended March 31, 2024

 

Specialty
Property &
Casualty
Insurance

 

Insurance
Distribution

 

Corporate &
Other

 

Consolidated

($ in thousands)

 

 

 

 

 

 

 

 

Gross premiums written

 

$

96,422

 

 

 

 

 

 

$

96,422

 

Net premiums written

 

 

26,247

 

 

 

 

 

 

 

26,247

 

Total revenues from Continuing Operations

 

 

29,542

 

 

 

17,865

 

 

 

2,145

 

 

 

49,551

 

Total expenses from Continuing Operations

 

 

27,721

 

 

 

13,892

 

 

 

11,177

 

 

 

52,790

 

Pretax income (loss)

 

 

1,821

 

 

 

3,973

 

 

 

(9,032

)

 

 

(3,239

)

Provision (benefit) for income taxes

 

 

106

 

 

 

118

 

 

 

(94

)

 

 

130

 

Net income (loss) from Continuing Operations

 

$

1,715

 

 

$

3,855

 

 

$

(8,938

)

 

$

(3,369

)

 

 

 

 

 

 

 

 

 

Adjustments to EBITDA

 

 

 

 

 

 

 

 

Add: Interest expense

 

 

 

$

 

 

 

 

$

 

Add: Income tax expense

 

 

106

 

 

 

118

 

 

 

(94

)

 

 

130

 

Add: Depreciation

 

 

 

 

 

10

 

 

 

465

 

 

 

475

 

Add: Intangible amortization

 

 

 

 

1,139

 

 

 

 

 

1,139

 

EBITDA from Continuing Operations

 

$

1,821

 

 

$

5,122

 

 

$

(8,567

)

 

$

(1,625

)

EBITDA from Continuing Operations attributable to

Ambac shareholders

 

$

1,872

 

 

$

4,202

 

 

$

(5,689

)

 

$

1,304

 

 

 

 

 

 

 

 

 

 

Adjustments to Adjusted EBITDA

 

 

 

 

 

 

 

 

Add: Acquisition and integration related expenses

 

$

 

 

$

 

 

$

569

 

 

$

569

 

Add: Equity-based compensation expense

 

 

51

 

 

 

 

 

 

2,129

 

 

 

2,180

 

Add: Severance and restructuring expense

 

 

 

 

 

 

 

 

134

 

 

 

134

 

Add: Other non-operating (income) losses

 

 

 

 

 

 

 

 

48

 

 

 

48

 

Adjusted EBITDA from Continuing Operations

 

 

1,872

 

 

 

5,122

 

 

 

(5,689

)

 

 

1,304

 

Adjusted EBITDA from Continuing Operations attributable to

Ambac shareholders

 

$

1,872

 

 

$

4,202

 

 

$

(5,689

)

 

$

384

 

 

 

 

 

 

 

 

 

 

Net income (loss) (Continuing Operations)

 

$

1,715

 

 

$

3,782

 

 

$

(8,976

)

 

$

(3,479

)

Adjustments:

 

 

 

 

 

 

 

 

Add: Acquisition and integration related expenses

 

 

 

 

 

 

 

 

569

 

 

 

569

 

Add: Intangible amortization

 

 

 

 

 

1,139

 

 

 

 

 

 

1,139

 

Add: Equity-based compensation expense

 

 

51

 

 

 

 

 

 

2,129

 

 

 

2,180

 

Add: Severance and restructuring expense

 

 

 

 

 

 

 

 

134

 

 

 

134

 

Add: Other non-operating (income) losses

 

 

 

 

 

 

 

 

48

 

 

 

48

 

Adjusted net income (loss) before tax and NCI

 

 

1,766

 

 

 

4,921

 

 

 

(6,096

)

 

 

591

 

Income tax effects

 

 

 

 

 

 

 

 

 

 

 

 

Adjusted net income (loss) before NCI

 

 

1,766

 

 

 

4,921

 

 

 

(6,096

)

 

 

591

 

Net (income) loss attributable to noncontrolling interest

 

 

 

 

 

(920

)

 

 

 

 

 

(920

)

Adjusted net income (loss) attributable to common shareholders

 

$

1,766

 

 

$

4,001

 

 

$

(6,096

)

 

$

(329

)

 

 

 

 

 

 

 

 

 

Net income (loss) margin

 

 

5.8

%

 

 

21.2

%

 

 

NM

 

 

 

(7.0

)%

Adjusted EBITDA Margin

 

 

6.3

%

 

 

28.7

%

 

 

NM

 

 

 

2.6

%

Adjusted EBITDA Margin to Ambac shareholders

 

 

6.3

%

 

 

23.5

%

 

 

NM

 

 

 

0.8

%

Adjusted Net income (loss) after NCI margin

 

 

6.0

%

 

 

22.4

%

 

 

NM

 

 

 

(0.7

)%

 

 

 

 

 

 

 

 

 

 

Organic Growth

 

 

Three Months Ended December 31,

($ in thousands)

 

 

2025

 

 

 

2024

 

 

% Growth

Total Insurance Distribution revenue (1)

$

40,998

 

 

$

17,865

 

 

129%

Less: Acquired revenues

 

(19,971

)

 

 

 

 

Less: Profit commission and contingent commission income

 

(4,691

)

 

 

(1,182

)

 

 

Total Organic Revenue & Growth Percentage

 

16,336

 

 

 

16,683

 

 

(2.1)%

(1)

Total Insurance Distribution revenue includes investment income

 

Total Specialty P&C Insurance Production

Specialty P&C Insurance production, which includes gross premiums written by Ambac's Specialty P&C Insurance segment and premiums placed by the Insurance Distribution segment.

 

 

 

Three Months Ended March 31,

($ in thousands)

 

 

2025

 

2024

 

% Change

Specialty Property & Casualty Insurance Gross Premiums Written

 

 

$

86,915

 

$

96,422

 

(10)%

Insurance Distribution Premiums Placed

 

 

 

230,606

 

 

90,096

 

156%

Specialty P&C Insurance Production

 

 

$

317,521

 

$

186,518

 

70%

 

About Ambac

Ambac Financial Group, Inc. (“Ambac” or “AFG”) is an insurance holding company headquartered in New York City. Ambac’s core business is a growing specialty P&C distribution and underwriting platform. Ambac also has a legacy financial guarantee business in run-off which we have agreed to sell to funds managed by Oaktree Capital Management pending regulatory approval. Ambac’s common stock trades on the New York Stock Exchange under the symbol “AMBC”. Ambac is committed to providing timely and accurate information to the investing public, consistent with our legal and regulatory obligations. To that end, we use our website to convey information about our businesses, including the anticipated release of quarterly financial results, quarterly financial, statistical and business-related information. For more information, please go to www.ambac.com.

The Amended and Restated Certificate of Incorporation of Ambac contains substantial restrictions on the ability to transfer Ambac’s common stock. Subject to limited exceptions, any attempted transfer of common stock shall be prohibited and void to the extent that, as a result of such transfer (or any series of transfers of which such transfer is a part), any person or group of persons shall become a holder of 5% or more of Ambac’s common stock or a holder of 5% or more of Ambac’s common stock increases its ownership interest.

Forward-Looking Statements

In this press release, statements that may constitute “forward-looking statements” within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Words such as “estimate,” “project,” “plan,” “believe,” “anticipate,” “intend,” “planned,” “potential” and similar expressions, or future or conditional verbs such as “will,” “should,” “would,” “could,” and “may,” or the negative of those expressions or verbs, identify forward-looking statements. We caution readers that these statements are not guarantees of future performance. Forward-looking statements are not historical facts, but instead represent only our beliefs regarding future events, which may by their nature be inherently uncertain and some of which may be outside our control. These statements may relate to plans and objectives with respect to the future, among other things which may change. We are alerting you to the possibility that our actual results may differ, possibly materially, from the expected objectives or anticipated results that may be suggested, expressed or implied by these forward-looking statements. Important factors that could cause our results to differ, possibly materially, from those indicated in the forward-looking statements include, among others, those discussed under “Risk Factors” in our most recent SEC filed quarterly or annual report.

Any or all of management’s forward-looking statements here or in other publications may turn out to be incorrect and are based on management’s current belief or opinions. Ambac Financial Group’s (“AFG”) and its subsidiaries’ (collectively, “Ambac” or the “Company”) actual results may vary materially, and there are no guarantees about the performance of Ambac’s securities. Among events, risks, uncertainties or factors that could cause actual results to differ materially are: (1) the high degree of volatility in the price of AFG’s common stock; (2) failure to consummate the proposed sale of all of the common stock of Ambac Assurance Corporation (“AAC”) and the transactions contemplated by the related stock purchase agreement (the “Sale Transactions”) in a timely manner or at all; (3) disruptions from the proposed Sale Transactions, including from litigation, that may harm Ambac’s business, including current plans and operations; (4) potential adverse reactions or changes to business relationships resulting from the announcement or completion of the proposed Sale Transactions; (5) uncertainty concerning the Company’s ability to achieve value for holders of its securities from the specialty property and casualty insurance business, the insurance distribution business, or related businesses; (6) inadequacy of reserves established for losses and loss expenses and the possibility that changes in loss reserves may result in further volatility of earnings or financial results; (7) risks historically reported by the Company with respect to the legacy financial guarantee business, which may continue to affect the Company if the Sale Transactions are not consummated; (8) credit risk throughout Ambac’s business, including but not limited to exposures to reinsurers and insurance distribution partners; (9) the Company’s inability to generate the significant amount of cash needed to service its debt and financial obligations, and its inability to refinance its indebtedness; (10) the Company’s substantial indebtedness could adversely affect the Company’s financial condition and operating flexibility; (11) the Company may not be able to obtain financing, refinance its outstanding indebtedness, or raise capital on acceptable terms or at all due to its substantial indebtedness and financial condition; (12) greater than expected underwriting losses in the Company’s specialty property and casualty insurance business; (13) failure of specialty insurance program partners to properly market, underwrite or administer policies; (14) inability to obtain reinsurance coverage or charge rates for insurance on expected terms; (15) loss of key relationships for production of business in specialty property and casualty and insurance distribution businesses or the inability to secure such additional relationships to produce expected results; (16) the impact of catastrophic public health, environmental or natural events, or global or regional conflicts; (17) the risk that the Company’s risk management policies and practices do not anticipate certain risks and/or the magnitude of potential for loss; (18) restrictive covenants in agreements and instruments that impair Ambac’s ability to pursue or achieve its business strategies; (19) disagreements or disputes with the Company’s insurance regulators; (20) failure of a financial institution in which we maintain cash and investment accounts; (21) adverse impacts from changes in prevailing interest rates; (22) events or circumstances that result in the impairment of our intangible assets and/or goodwill that was recorded in connection with Ambac’s acquisitions; (23) the risk of litigation, regulatory inquiries, investigations, claims or proceedings, and the risk of adverse outcomes in connection therewith; (24) the Company’s ability to adapt to the rapid pace of regulatory change; (25) actions of stakeholders whose interests are not aligned with broader interests of Ambac's stockholders; (26) system security risks, data protection breaches and cyber attacks; (27) failures in services or products provided by third parties; (28) political developments that disrupt the economies where the Company has insured exposures or the markets in which our insurance programs operate; (29) our inability to attract and retain qualified executives, senior managers and other employees, or the loss of such personnel; (30) fluctuations in foreign currency exchange rates; (31) failure to realize our business expansion plans, including failure to effectively onboard new program partners, or failure of such plans to create value; (32) greater competition for our specialty property and casualty insurance business and/or our insurance distribution business; (33) loss or lowering of the AM Best rating for our property and casualty insurance company subsidiaries; (34) disintermediation within the insurance industry or greater competition from technology-based insurance solutions or non-traditional insurance markets; (35) adverse effects of market cycles in the property and casualty insurance industry; (36) variations in commission income resulting from timing of policy renewals and the net effect of new and lost business production; (37) variations in contingent commissions resulting from the effects insurance losses; (38) reliance on a limited number of counterparties to produce revenue in our specialty property and casualty insurance and insurance distribution businesses; (39) changes in law or in the functioning of the healthcare market that impair the business model of our accident and health managing general underwriter; (40) difficulties in identifying appropriate acquisition or investment targets, properly evaluating the business and prospects of acquired businesses, businesses in which we invest, or targets, integrating acquired businesses into our business or failures to realize expected synergies from acquisitions or new business investments; (41) failure to realize expected benefits from investments in technology; (42) harmful acts and omissions of our business counterparts; and (43) other risks and uncertainties that have not been identified at this time.

Contacts

Charles J. Sebaski
Managing Director, Investor Relations
(212) 208-3222
csebaski@ambac.com

Ambac Financial Group, Inc.

NYSE:AMBC

Release Summary
Ambac Reports First Quarter 2025 Results
Release Versions

Contacts

Charles J. Sebaski
Managing Director, Investor Relations
(212) 208-3222
csebaski@ambac.com

Social Media Profiles
More News From Ambac Financial Group, Inc.

Ambac to Release First Quarter 2025 Results on May 12, 2025

NEW YORK--(BUSINESS WIRE)--Ambac to Release First Quarter 2025 Earnings on May 12, 2025...

Ambac Financial Group, Inc. Provides Update on the Sale of Its Legacy Financial Guarantee Business

NEW YORK--(BUSINESS WIRE)--Ambac Financial Group Provides Update on the Sale of its Legacy Financial Guarantee Business...

Ambac Announces Meeting and Record Date for 2025 Annual Meeting of Stockholders

NEW YORK--(BUSINESS WIRE)--Ambac Announces Meeting and Record Date for 2025 Annual Meeting of Stockholders...
Back to Newsroom